may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful..

this procedure is mostly done as an outpatient, meaning the patient is discharged the same day.. (image: rex/shutterstock).

fda commissioner: it�s not a secret, sir. many experts know about it..

more from the doncaster free press